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NOCTURNAL DIURESIS RATE PATTERNS IN NOCTURNAL
POLYURIA SYNDROME AND SECONDARY NOCTURNAL
POLYURIA
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Nicholas Suss, Arturo Holmes, Brooklyn, NY; Donald Bliwise, Atlanta,
GA; Jason Lazar, Jeffrey Weiss, Brooklyn, NY
INTRODUCTION AND OBJECTIVES: In this study, we inves-
tigate how nocturnal diuresis rates differ at different portions of sleep for
5 different etiologies of nocturnal polyuria (NP) to aid in identifying
optimal management strategies for the distinct clinical entities of NP.
METHODS: We retrospectively analyzed a database of voiding
diaries from patients managed for nocturia at a Veterans Affairs urology
clinic from 2007-2018. The first complete entries were included for
males aged 18 with clinically-significant nocturia (2 nocturnal voids)
owing to NP using the two most common definitions of NP: nocturnal
urine production [NUP] 90 mL/h and nocturnal polyuria index
[NPi] 0.33. Patients meeting criteria were divided into 5 sub-groups
with a single diagnosis of either Nocturnal Polyuria Syndrome (NPS),
diabetes insipidus (DI), obstructive sleep apnea (OSA), congestive
heart failure (CHF), and chronic kidney disease (CKD). NPS was
defined as NP in the absence of all aforementioned diagnoses. Early
nocturnal diuresis rate (ENDR), defined as first nocturnal voided
volume/first uninterrupted sleep period, late nocturnal diuresis rate
(LNDR), defined as remaining nocturnal urine volume/remaining hours
of sleep, and diurnal diuresis rate (DDR), defined as daytime urine
volume/hours awake, were calculated and displayed with Wilcoxon
confidence intervals in Figure 1.
RESULTS: At both NUP90 mL/h and NPi 0.33, patients with
NPS demonstrated an increase in diuresis rate during the early portion
of sleep, followed by a decline in the latter portion of sleep, which fol-
lowed the same pattern for patients with DI with NP defined as
NUP 90 mL/h. Only 1 patient was identified with DI and NP defined as
NPi 0.33 following inclusion and exclusion criteria. At both
NUP 90mL/h and NPi 0.33, patients with OSA, CHF, and CKD were
observed to have a gradual increase in diuresis rate from early
nocturnal to the late nocturnal period.
CONCLUSIONS: Patients with NPS and DI exhibited an early
nocturnal surge in diuresis rate, followed by a decline in the latter
portion of sleep. In contrast, patients with NP of cardiogenic and renal
etiology displayed a gradual increase in diuresis rate from the early to
latter portion of sleep. Nocturia interventions may vary according to the
differing underlying mechanisms in these subtypes of nocturnal
polyuria.
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SALT INTAKE REDUCTION AS A TREATMENT OPTION FOR
OVERACTIVE BLADDER
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Yuichiro Nakamura, Yuji Sagara, Kojiro Ohba, Hideki Sakai, Nagasaki,
Japan
INTRODUCTION ANDOBJECTIVES: Although overactive bladder
(OAB) is primarily treated using anticholinergic drugs and b3 adrenergic
stimulants, patients are concerned regarding adverse events like dysuria,
dry mouth, constipation, and fluctuation of blood pressure, and there is a
particular desire for the emergence of safe treatments for elderly patients.
Chronic high salt intake is closely related to lifestyle diseases,
such as hypertension and diabetes, which have a significant influence
on the development of OAB. However, there are no studies that
examine the impact of salt reduction, a representative element of life-
style disease, on the OAB symptoms. This study aimed to analyze the
therapeutic effect of reducing salt intake in OAB patients.
METHODS: The subjects were OAB patients with excessive salt
intake (8 g/day for men and 7 g/day for women). OAB was defined as
an overactive bladder symptom score (OABSS) of 2 points for Q3
(urgency) and a total score of 3 points. The subjects were provided
nutrition guidance related to salt reduction every four weeks using bro-
chures. We prospectively examined urinary symptoms at the start of salt
reduction and 12 weeks into salt reduction using OABSS and the fre-
quency volume chart (FVC). The daily salt intake was estimated by
examining the sodium and creatinine concentrations of spot urine sam-
ples using a formula that was adjusted for body height, body weight, and
age. Value of P<0.05 was considered statistically significant.
RESULTS: A total of 98 subjects (52 men), with a mean age of
66.7  11.5 years were evaluated. During the observation period, 71
subjects (72.4%) achieved salt reduction (Success [S] Group), while 27
subjects (27.6%) did not (Failure [F] Group].
With respect to the OABSS, the S Group demonstrated an
improvement in not only Q1 (daytime frequency) and Q2 (nocturia) from
1.2  1.0 to 0.6  1.0 (P<0.001) and from 2.1  0.5 to 1.4  0.7
(P<0.001), respectively, but also in Q3 (urgency), Q4 (urgency incon-
tinence), and total score from 2.3  0.5 to 2.0  0.7 (P<0.001), from
1.3  1.0 to 1.1  1.0 (P[0.003), and from 6.9  1.0 to 5.1  2.2
(P<0.001), respectively. With respect to FVC, the S group showed
improvement in voided volume from 247.8  25.1 mL to 260.4 
32.6 mL (P<0.001), and nocturia from 2.5  1.0 times to 1.6  0.9 times
(P<0.001). The F group showed no improvement in any of the pa-
rameters of OABSS and FVC.
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